Delivery Order SPE2DB24D1104-SPE2DB25FYDW0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.94 firm fixed-price delivery order is for the supply of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has a ceiling value of $1,668.36 and an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,314.25 firm fixed-price contract is for the delivery of ROPINIROLE HCL ER 8 MG tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract is a firm fixed-price delivery order with a ceiling value of $1,391.68 and a period of performance through April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award, valued at $3,048.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,306,539 tablets of Ropinirole HCl 1 mg, a medication used for the treatment of Parkinson's disease and restless leg syndrome. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 4, 2024. It...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 MG tablets, a medication commonly used to treat Parkinson's disease and restless leg syndrome. The contract has a firm-fixed price of $1,292.25 and a completion date of June 18, 2025. This contract is not set aside and is open to full and open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,149.62 delivery order contract is for the supply of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of July 17, 2024 and is a firm-fixed price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $5,759.27, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract is for the delivery of Ropinirole HCL ER 6 mg tablets, a medication commonly used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The award has a ceiling value of $7,780.64 and an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDW0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,676.05 to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 8 mg tablets (30-count package), a generic medication primarily used to treat Parkinson's disease and restless leg syndrome. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The award date of July 29, 2025, with an ultimate completion date of July 30, 2025, reflects the expedited nature of this delivery order. Performance will occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded, non-set-aside contract awards demonstrates its capability to meet federal procurement requirements and its significance as a critical pharmaceutical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/29/25 |